Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《International Eye Science》 2019-04
Add to Favorite Get Latest Update

Effect of intravitreal injection of conbercept on neovascular age-related macular degeneration

Tao Li;Shuang-Le Li;Department of Ophthalmology, Zigong No.1 People's Hospital;  
AIM: To investigate the efficacy of intravitreal injection of conbercept on neovascular age-related macular degeneration(ARMD) and its effect on choroidal thickness. METHODS: A total of 213 patients(345 eyes) with ophthalmologic diseases who were treated in our hospital from March 2014 to December 2017 were randomly divided into control group(n=106, 176 eyes) and observation group(n=107, 169 eyes). The control group was treated with intravitreal injection of triamcinolone acetonide and the observation group was treated with intravitreal injection of conbercept. The efficacy of the two groups and changes in choroidal thickness were compared and analyzed. RESULTS: There was no significant difference in BCVA and CMT between the two groups before and after injection(P0.05). However, BCVA and CMT in observation group and control group were significantly better than those before injection(P0.05), and there was significant difference between before and after injection. There was no significant difference in central retinal thickness and choroid thickness between the two groups at baseline(1, 3, 6 mo)(P0.05). However, the central retinal thickness and choroid thickness at 6 mo were significantly lower than those at baseline and 1, 3 mo(P0.05), which were statistically significant. After treatment, the total incidence of complications in the observation group and the control group were 5.7% and 7.7%, respectively, with no significant difference between the two groups(P0.05). CONCLUSION: Intravitreal injection of conbercept and triamcinolone acetonide has the same effect, which can not only improve and stabilize the visual acuity of patients, but also reduce the central retinal thickness and choroid thickness effectively. It has obvious curative effect and high safety, and has clinical application value.
【CateGory Index】: R774.5
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Citations】
Chinese Journal Full-text Database 5 Hits
1 Jiao Mingfei;Li Xiaorong;Tianjin Medical University Eye Hospital,School of Optometry and Ophthalmology,TMU,Tianjin Medical University Eye Institute;;Clinical safety and efficacy of conbercept intravitreal injection on high myopic choroidal neovascularization[J];中华实验眼科杂志;2016-08
2 Yu Lan;Chen Changzheng;Su Yu;Yi Zuohuizi;Zhou Yunyun;Qi Hang;Liang Chaoqun;Xu Yishuang;Eye Center,Renmin Hospital of Wuhan University;;Clinical observation of intravitreal injection of Conbercept treating idiopathic choroidal neovascularization[J];中华眼底病杂志;2016-01
3 Zeng Miao;Song Yanping;Ding Qin;Wuhan General Hospital of Guangzhou Military Command;;Intravitreal Conbercept for treatment of choroidal neovascularization secondary to pathologic myopia[J];中华眼底病杂志;2016-01
4 Yu Lan;Chen Changzheng;Yizuo Huizi;Eye Center,People′s Hospital of Wuhan University;;Clinical observation of intravitreal injection of Conbercept treating exudative age-related macular degeneration[J];中华眼底病杂志;2015-03
5 Wen-Jie Liu,Lei Gao,Chang-Xia Dong,Hua-Jun Yu,Kai Jiang,Xü-Ming Lin Department of Ophthalmology,Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University,Yantai 264000,Shandong Province,China;Intravitreal injection of Bevacizumab in treatment of AMD[J];国际眼科杂志;2010-03
【Co-citations】
Chinese Journal Full-text Database 10 Hits
1 Liu Weifeng;Huang Guofu;Liu Lili;Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University;Department of Ophthalmology, The Eye Hospital of Nanchang University;;The progress pattern and natural courses of myopic macularpathy[J];中华眼底病杂志;2018-05
2 Dai Qing;Gao Ziqing;Department of Ophthalmology,the First Affiliated Hospital of Bengbu Medical College;;Observation of short-term efficacy of continuous intravitreal injection of conbercept for the treatment of wAMD[J];中华解剖与临床杂志;2018-02
3 Shang Lixiao;Deparment of Ophthalmology,The First Affiliated Hospital of Henan University of Science and Technology,Clinical Medicine College of Henan University of Science and Technology;;Intravitreal injection of Conbercept combined surgery and photocoagulation for the treatment of neovascular glaucoma[J];中华眼外伤职业眼病杂志;2018-02
4 Wu Tengfei;Guo Xiuhua;Xiang Yihui;Fu Ying;Department of Ophthalmology,Beijing Miyun Teaching Hospital Affiliated to Capital Medical University;;Observation on the efficacy of Conbercept for the treatment of exudative age-related macular degeneration[J];中华眼外伤职业眼病杂志;2018-02
5 Deng Xiao;Yu Zhaomin;Department of Ophthalmology,Meizhou People's Hospital;;Correlation between ocular fundus characteristics,diopter and best corrected visual acuity in young patients with high myopia[J];中国实用医刊;2017-23
6 Yang Lin;Jin Xuemin;Zhou Pengyi;Department of Ophthalmology, The First Affiliated hospital of Zhengzhou University;;Intravitreal injection of bevacizumab or ranibizumab for the treatment of pathological myopia choroidal neovascularization[J];中华眼底病杂志;2017-02
7 Hu Hongge;Jin Xuemin;Department of Ophthalmology,Xuchang Municipal Center Hospital;Department of Ophthalmology,the First Affiliated Hospital of Zhengzhou University;;Intravitreal injection of bevacizumab combined with Ahmed drainage valve implantation for the treatment of neovascular glaucoma[J];中华眼外伤职业眼病杂志;2016-06
8 Yu Lan;Chen Changzheng;Su Yu;Yi Zuohuizi;Zhou Yunyun;Qi Hang;Liang Chaoqun;Xu Yishuang;Eye Center,Renmin Hospital of Wuhan University;;Clinical observation of intravitreal injection of Conbercept treating idiopathic choroidal neovascularization[J];中华眼底病杂志;2016-01
9 Zhen-Liu Zhu;Yun-Xia Liu;Department of Ophthalmology,An Qiu People's Hospital;Department of Emergency,An Qiu People's Hospital;;Clinical effect of Conbercept to improve visual acuity of patients with wet age-related macular degeneration[J];国际眼科杂志;2015-11
10 Zeng Renpan;Liang Xiaoqiong;Wang Guoping;He Pengfei;Zhou Jianli;Department of Ophthalmology,Sichuan Provincial Corps Hospital,Chinese People's Armed Police Forces;;Evaluation of the effect of Conbercept intravitreal injection on wet age-related macular degeneration[J];临床眼科杂志;2015-03
【Secondary Citations】
Chinese Journal Full-text Database 9 Hits
1 Yu Lan;Chen Changzheng;Yizuo Huizi;Eye Center,People′s Hospital of Wuhan University;;Clinical observation of intravitreal injection of Conbercept treating exudative age-related macular degeneration[J];中华眼底病杂志;2015-03
2 Qi Hang;Chen Changzheng;Yizuo Huizi;Eye Center,Renmin Hospital of Wuhan University;;Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization[J];中华眼底病杂志;2015-01
3 Ophthalmology Division of Chinese Medical Association;;Top ten research advances of ophthalmology in China(2009-2013)[J];中华眼科杂志;2014-08
4 ZHANG Jun-jun,ZHANG Mei-xia.Department of Ophthalmology,West China Hospital,Sichuan University,Chengdu 610041,China;Choice of the treating methods of neovascular age-related macular degeneration[J];中华实验眼科杂志;2012-11
5 YUE Mei,DAI Hong,YU Xiao-bing,et al.Department of Ophthalmology,Beijing Hospital,Beijing 100730,China;Clinical observation of intravitreal injection of ranibizumab for idiopathic choroidal neovascularization[J];中华眼底病杂志;2011-06
6 HUANG Chuang-xin,JI Jie,TIAN Zhen,et al.Zhongshan Ophthalmic Center,Sun Yat-Sen University,State Key Laboratory of Ophthalmology,Guangzhou 510060,China;Clinical observation of photodynamic therapy for choroidal neovascularization secondary to pathological myopia[J];中华眼底病杂志;2011-06
7 DAI Hong,YANG Xu,YU Xiao-bing,et al.Ophthalmology of Beijing Hospital,Beijing 100730,China;Clinical observation of intravitreal injection of Ranibizumab for exudative age-related macular degeneration[J];中华眼底病杂志;2008-03
8 YE Xiang-xiang*,CHEN Zhong-shan,DING Qin,et al.*Eye Center of PLA,Wuhan General Hospital of Guangzhou Military,Wuhan 430070,China;Intravitreal ranibizumab injection combined with or without photodynamic therapy for idiopathic choroidal neovascularization:a comparative efficacy study[J];中华眼底病杂志;2013-04
9 YIZUO Hui-zi,CHEN Chang-zheng,ZHENG Hong-mei,et al.Eye Center,Renmin Hospital of Wuhan University,Wuhan 430060,China;Clinical observation of intravitreal ranibizumab for treatment of choroidal neovascularization secondary to pathologic myopia[J];中华眼底病杂志;2013-04
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved